Poster & Publications

EZH2 inhibition: a promising strategy to prevent cancer immune editing

February 16, 2024

Share
Tweet
Share on Facebook
Share

Paper titled:EZH2 inhibition: a promising strategy to prevent cancer immune editing.

Kang, Eccleston, Clermont et al

Published in Epigenomics 2020

Download

Related Articles

Poster & Publications
Circulating H3K27me3 modified nucleosomes as a biomarker to monitor anti EZH2-based treatment in advanced solid tumour patients
Poster & Publications
Novel ctDNA technology for early cancer detection by immunoprecipitation of tumor associated ctDNA fragments and analysis by qPCR

Share
Tweet
Share on Facebook
Share

Subscribe for Volition product updates.

Or, click here for Investor Updates and press releases.

"*" indicates required fields

Receive product updates for:

Animal Health

Human Health

Name

First Name Last Name

Company Name*

Your Email Address*

CAPTCHA